Though relapsing-remitting multiple sclerosis, or RRMS, can be managed with many of the approved treatments for MS symptoms, there is still no scientifically proven, FDA-cleared way to predict when or if another relapse period will occur. There may be one on the horizon, however, since Quanterix recently received the regulator’s breakthrough device designation for a blood test designed to do exactly that.
https://www.fiercebiotech.com/medtec...fda-fast-track
https://www.fiercebiotech.com/medtec...fda-fast-track
Comment